G. Korpanty

发表

Lung cancer in never smokers from the Princess Margaret Cancer Centre

M. Tsao, F. Shepherd, S. Kamel‐Reid, 2018, Oncotarget.

2012 Publications of the Baylor Health Care System Medical and Scientific Staff

N. Geller, Y. Rosenberg, E. Schron, 2013 .

Treatment options for patients with brain metastases from EGFR/ALK-driven lung cancer.

M. Tsao, F. Shepherd, S. Kamel‐Reid, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Canadian Cancer Trials Group (CCTG) IND211: A randomized trial of pelareorep (Reolysin) in patients with previously treated advanced or metastatic non-small cell lung cancer receiving standard salvage therapy.

H. Feilotter, L. Seymour, F. Shepherd, 2018, Lung cancer.

Complete radiological response of metastatic anaplastic lymphoma kinase-positive signet ring lung adenocarcinoma to systemic chemotherapy.

D. Carney, N. Mulligan, G. Korpanty, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Primary bone lymphoma: single institution case series

D. Carney, D. Power, G. McVey, 2008, Irish journal of medical science.

A review of clinical and oncological outcomes following the introduction of the first robotic colorectal surgery programme to a university teaching hospital in Ireland using a dual console training platform

D. O'Leary, R. Sehgal, J. Coffey, 2020, Journal of Robotic Surgery.

Loss of fibulin-5 binding to β1 integrins inhibits tumor growth by increasing the level of ROS

R. Brekken, Marie K. Schluterman, T. Fukai, 2010, Disease Models & Mechanisms.

Urinary leukotriene levels are increased during exacerbation of atopic eczema/dermatitis syndrome. Relation to clinical status

L. Mastalerz, A. Szczeklik, G. Czerniawska-Mysik, 2002, Allergy.

Is chemotherapy always required for cancer in pregnancy? An observational study

D. Carney, K. Cadoo, G. O’Kane, 2017, Irish Journal of Medical Science (1971 -).

Phyllodes tumor of the breast

J. McCaffrey, D. Power, M. Kell, 2011, Medical oncology.

Update on anti-angiogenic therapy in non-small cell lung cancer: Are we making progress?

D. Carney, E. Smyth, G. Korpanty, 2011, Journal of thoracic disease.

Association of BRM promoter polymorphisms and esophageal adenocarcinoma outcome

A. Azad, G. Darling, Geoffrey Liu, 2017, Oncotarget.

Prognostic and predictive effects of TP53 co-mutation in patients with EGFR-mutated non-small cell lung cancer (NSCLC).

M. Tsao, F. Shepherd, S. Kamel‐Reid, 2017, Lung cancer.

Barriers to implementation

N. Leighl, G. Korpanty, 2012 .

Biomarkers That Currently Affect Clinical Practice in Lung Cancer: EGFR, ALK, MET, ROS-1, and KRAS

M. Vincent, N. Leighl, D. Graham, 2014, Front. Oncol..

Monitoring Response to Anticancer Therapy by Targeting Microbubbles to Tumor Vasculature

Rolf A. Brekken, P. Grayburn, J. Fleming, 2007, Clinical Cancer Research.

Forced Expression of MMP9 Rescues the Loss of Angiogenesis and Abrogates Metastasis of Pancreatic Tumors Triggered by the Absence of Host SPARC

R. Brekken, S. Mañes, S. Arnold, 2008, Experimental biology and medicine.

Anti-VEGF strategies - from antibodies to tyrosine kinase inhibitors: background and clinical development in human cancer.

E. Smyth, G. Korpanty, 2012, Current pharmaceutical design.

ALK‐Rearranged Non–Small‐Cell Lung Cancer Is Associated With a High Rate of Venous Thromboembolism

M. Tsao, F. Shepherd, Geoffrey Liu, 2017, Clinical lung cancer.

Molecular and Clinical Aspects of Targeting the VEGF Pathway in Tumors

Laura A. Sullivan, R. Brekken, D. Carney, 2010, Journal of oncology.

Antiangiogenic therapy in lung cancer: focus on vascular endothelial growth factor pathway

Laura A. Sullivan, R. Brekken, D. Carney, 2010, Experimental biology and medicine.

Small-cell carcinoma of the cervix at 23 weeks gestation.

J. McCaffrey, D. Carney, N. Mulligan, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Update on vascular disrupting agents for cancer therapy

R. Brekken, G. Korpanty, 2011 .

Contrast Ultrasound in Imaging Tumor Angiogenesis

R. Brekken, G. Korpanty, 2010 .

Targeting vascular endothelium with avidin microbubbles.

R. Shohet, P. Grayburn, R. Brekken, 2005, Ultrasound in medicine & biology.

[Self-estimation of the quality of life in adult patients after surgical correction of atrial septal defect type II (ASD II)].

B. Guzik, G. Korpanty, R. Pfitzner, 2001, Przeglad lekarski.

Targeting of VEGF-mediated angiogenesis to rat myocardium using ultrasonic destruction of microbubbles

R V Shohet, R. Shohet, P. Grayburn, 2005, Gene Therapy.

A Randomized Phase II Study of FOLFOX6/Bevacizumab With or Without Pelareorep in Patients With Metastatic Colorectal Cancer: IND.210, a Canadian Cancer Trials Group Trial

H. Feilotter, L. Seymour, M. Tsao, 2018, Clinical colorectal cancer.

Prognostic and predictive effects of TP53 mutation in patients with EGFR-mutated non-small cell lung cancer (NSCLC).

M. Tsao, F. Shepherd, S. Kamel‐Reid, 2016 .

Tumor Vasculature as a Target for Cancer Therapy

R. Brekken, Xianming Huang, G. Korpanty, 2005 .

Loss of fibulin-5 binding to β1 integrins inhibits tumor growth by increasing the level of ROS

R. Brekken, Marie K. Schluterman, T. Fukai, 2010, Disease Models & Mechanisms.

Prognostic and predictive effects of TP53 co-mutation in patients with EGFR-mutated non-small cell lung cancer (NSCLC).

M. Tsao, F. Shepherd, S. Kamel‐Reid, 2017, Lung cancer.

Metastatic melanoma in the Mid-West of Ireland: a retrospective review

B. Ramsay, G. Korpanty, I. Timoney, 2022, Irish Journal of Medical Science (1971 -).